2025 News Feed
Opportunities to Contribute to Science
To date, more than 65,000 people have been screened to participate in a clinical trial at Pennington Biomedical Research Center. Kytara Gaudin Christophe and her daughter, Chloe, share their experiences as Pennington Biomedical trial participants.
Learn More
Pennington Biomedical’s Pediatric Obesity and Health Behavior Laboratory Authors Childhood Obesity’s Most Downloaded Paper of 2024
"Closing the Gap Between Evidence and Practice for Childhood Obesity Treatment," authored by Pennington Biomedical’s Pediatric Obesity and Health Behavior Laboratory’s Dr. Amanda Staiano and Dr. Alyssa Button, was the most downloaded paper in 2024 from Childhood Obesity, a leading peer-reviewed journal dedicated to strategies for obesity prevention and weight management in children and adolescents.
Learn More
Pennington Biomedical Researchers Serve on Global Commission on Clinical Obesity that Goes Beyond BMI in Defining Obesity as a Disease
Three researchers from Pennington Biomedical Research Center served on the Lancet Commission on Clinical Obesity, a global group that generated a new approach to diagnosing clinical obesity. The diagnosis is based on evaluations in addition to body mass index, or BMI, such as measures of excess body fat and objective signs and symptoms of ill health at the individual level.
Learn More
The Lancet Diabetes & Endocrinology: Global Commission Proposes Major Overhaul of Obesity Diagnosis
A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by more than 75 medical organisations around the world, presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level.
Learn More
Monoclonal Antibody Ponsegromab Shown to Reduce Effects of Cancer-Related Wasting Syndrome
Cachexia, also known as wasting syndrome, commonly occurs in patients with certain cancers, leading to dangerous weight loss and functional impairment. Medicinal treatments for this condition are rare, but a recent study demonstrated that the antibody ponsegromab is both safe and effective in treating muscle wasting and weight loss in cancer patients. Pennington Biomedical Research Center was one of more than 70 facilities globally to host the study testing the efficacy of this antibody.
Learn More
Global Launch for Clinical Obesity Definition to be Held Jan. 16, Pennington Biomedical Serving as North American Satellite Hub
The Lancet Commission on Clinical Obesity, a globally representative group of 56 worldwide experts, are publishing the first ever definition of clinical obesity at a launch event on Jan. 16. The event will be teleconferenced to various locations across the globe originating from the Royal College of Physicians in London, with the Pennington Biomedical Research Center serving as the satellite site for North America.
Learn More
LSU and Pennington Biomedical’s Stephania Cormier Serves as Frontiers in Immunology Topic Editor on “How RSV Outsmarts the Host”
LSU and Pennington Biomedical Research Center’s Dr. Stephania Cormier joined colleagues Dr. Lawrence Kauvar of Trellis Bioscience Inc. and Dr. Ralph Tripp of the University of Georgia as topic editors on the Frontiers in Immunology research collaboration, “How RSV Outsmarts the Host,” focusing on challenges surrounding Respiratory Syncytial Virus, or RSV.
Learn More
U.S. News & World Report’s 2025 Best Diets: DASH Diet Recognized as Best Heart-Healthy Diet, Ranks as Second-Best Diet Overall
The Dietary Approaches to Stop Hypertension, or DASH, Diet, developed in part by Pennington Biomedical Research Center scientists, has been recognized as the second-best diet overall and the best heart-healthy diet in the 2025 U.S. News & World Report Best Diets Rankings.
Learn More
